BioNeutra Global Corporation announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CAD 37.700 million compared to CAD 37.717 million a year ago. Net loss was CAD 12.443 million compared to net income of CAD 3.103 million a year ago. Basic loss per share was CAD 0.27 compared to basic earnings per share of CAD 0.07 a year ago.